Glucosamine Market Size (2024 - 2029)

The glucosamine market is experiencing growth due to rising health consciousness and an increase in bone and joint conditions linked to sedentary lifestyles. As a dietary supplement in the United States and a prescribed drug in Europe, glucosamine's market size is influenced by its use in combination with other health-promoting ingredients. The trend towards preventive health measures is expected to further drive the market's expansion during the forecast period.

Market Size of Glucosamine Industry

glucosamine market size
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 3.80 %
Fastest Growing Market Europe
Largest Market Europe
Market Concentration Low

Major Players

glucosamine market major players

*Disclaimer: Major Players sorted in no particular order

Glucosamine Market Analysis

The Global Glucosamine Market is projected to register a CAGR of 3.8% over the forecast period (2020-2025). Glucosamine is a common supplement used for the treatment of knee osteoarthritis.

  • Glucosamine is legally regarded as a dietary supplement in the United States. However, it is a prescribed drug in Europe. Increased sedentary lifestyle among the general population in these regions is increasing the incidence of bone and joint conditions which has propped up the market for bone and joint supplements such as glucosamine.

  • Glucosamine is also being used in combination with other ingredients such as collagen peptides, hyaluronic acid, vitamins, and traditional herbs. The increased health consciousness of consumers is expected to propel the market for glucosamine further during the forecast period.

Glucosamine Industry Segmentation

The Global Glucosamine Market is segmented by application into food and beverages, nutritional supplements, dairy products, and other applications. The market is segmented by geography to include the market trends of top countries in North America, Europe, Asia-Pacific, South America and Middle-East & Africa.

Application
Food & Beverages
Nutritional Supplements
Dairy Products
Other Appkications
Geography
North America
United States
Canada
Mexico
Rest of North America
Europe
Germany
United Kingdom
France
Spain
Russia
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
Rest of Asia-Pacific
South America
Brazil
Argentina
Rest of South America
Middle East and Africa
Saudi Arabia
South Africa
Rest of Middle East and Africa
Need A Different Region Or Segment?
Customize Now

Glucosamine Market Size Summary

The glucosamine market is experiencing steady growth, driven by increasing health consciousness and a rising incidence of bone and joint conditions due to sedentary lifestyles. As a dietary supplement in the United States and a prescribed drug in Europe, glucosamine is primarily used for treating knee osteoarthritis. The market is further propelled by the combination of glucosamine with other health-enhancing ingredients like collagen peptides, hyaluronic acid, and traditional herbs. This trend is particularly evident among the aging populations in North America and Europe, where there is a significant demand for supplements that maintain bone health and prevent age-related diseases. Consumers are willing to pay premium prices for these products, which are perceived to offer targeted health benefits, thereby encouraging manufacturers to innovate and expand their product offerings.

In Europe, the glucosamine market is bolstered by a high prevalence of osteoarthritis and a strong awareness of health and wellness supplements. The region's demographic trends and health awareness levels contribute to the growing demand for bone and joint health supplements. The market is characterized by intense competition between global and local companies, with players seeking both organic growth through product innovation and geographical expansion, as well as strategic acquisitions to enhance their market presence. Companies such as Koyo Chemical Co., Ltd., Schiff Nutrition International Inc., and others are actively participating in this dynamic market landscape, aiming to capture a larger share of the growing demand for glucosamine products.

Explore More

Glucosamine Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Drivers

    2. 1.2 Market Restraints

    3. 1.3 Porter's Five Force Analysis

      1. 1.3.1 Bargaining Power of Suppliers

      2. 1.3.2 Bargaining Power of Buyers/Consumers

      3. 1.3.3 Threat of New Entrants

      4. 1.3.4 Threat of Substitute Products

      5. 1.3.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Application

      1. 2.1.1 Food & Beverages

      2. 2.1.2 Nutritional Supplements

      3. 2.1.3 Dairy Products

      4. 2.1.4 Other Appkications

    2. 2.2 Geography

      1. 2.2.1 North America

        1. 2.2.1.1 United States

        2. 2.2.1.2 Canada

        3. 2.2.1.3 Mexico

        4. 2.2.1.4 Rest of North America

      2. 2.2.2 Europe

        1. 2.2.2.1 Germany

        2. 2.2.2.2 United Kingdom

        3. 2.2.2.3 France

        4. 2.2.2.4 Spain

        5. 2.2.2.5 Russia

        6. 2.2.2.6 Italy

        7. 2.2.2.7 Rest of Europe

      3. 2.2.3 Asia-Pacific

        1. 2.2.3.1 China

        2. 2.2.3.2 Japan

        3. 2.2.3.3 India

        4. 2.2.3.4 Australia

        5. 2.2.3.5 Rest of Asia-Pacific

      4. 2.2.4 South America

        1. 2.2.4.1 Brazil

        2. 2.2.4.2 Argentina

        3. 2.2.4.3 Rest of South America

      5. 2.2.5 Middle East and Africa

        1. 2.2.5.1 Saudi Arabia

        2. 2.2.5.2 South Africa

        3. 2.2.5.3 Rest of Middle East and Africa

Glucosamine Market Size FAQs

The Glucosamine Market is projected to register a CAGR of 3.80% during the forecast period (2024-2029)

Koyo Chemical Co., Ltd., Schiff Nutrition International Inc., Zhejiang Aoxing Biotechnology Co., Ltd., Panvo Organics Pvt. Ltd. and Golden Shell Pharmaceutical Co., Ltd. are the major companies operating in the Glucosamine Market.

Glucosamine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)